SELLAS Life Sciences Group, Inc. (SLS)
11.54
-1.94
(-14.42%)
USD |
NASDAQ |
Sep 11, 16:00
11.56
+0.02
(+0.13%)
After-Hours: 20:00
SELLAS Life Sciences Group Price : 11.54 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 13.55 | 13.74 | 11.38 | 11.54 | 14.71M |
| Sep 10, 2026 | 13.66 | 13.82 | 13.37 | 13.49 | 4.830M |
| Sep 09, 2026 | 13.71 | 14.33 | 13.71 | 13.95 | 5.500M |
| Sep 08, 2026 | 13.77 | 14.37 | 13.32 | 13.96 | 6.055M |
| Sep 04, 2026 | 13.51 | 14.14 | 13.43 | 13.86 | 4.527M |
| Sep 03, 2026 | 14.06 | 14.54 | 13.55 | 13.70 | 5.783M |
| Sep 02, 2026 | 13.27 | 14.33 | 13.23 | 14.16 | 6.236M |
| Sep 01, 2026 | 13.02 | 13.39 | 12.64 | 13.22 | 5.912M |
| Aug 31, 2026 | 13.32 | 13.67 | 12.94 | 13.34 | 7.450M |
| Aug 28, 2026 | 14.77 | 14.79 | 13.15 | 13.21 | 9.825M |
| Aug 27, 2026 | 14.08 | 15.56 | 13.92 | 15.21 | 12.12M |
| Aug 26, 2026 | 13.82 | 13.92 | 13.41 | 13.73 | 4.595M |
| Aug 25, 2026 | 14.56 | 15.39 | 13.91 | 14.09 | 8.207M |
| Aug 24, 2026 | 15.48 | 15.48 | 13.91 | 14.32 | 8.823M |
| Aug 21, 2026 | 13.69 | 15.67 | 13.26 | 15.46 | 15.24M |
| Aug 20, 2026 | 13.84 | 14.44 | 13.01 | 13.40 | 7.819M |
| Aug 19, 2026 | 13.46 | 14.29 | 13.00 | 13.85 | 9.123M |
| Aug 18, 2026 | 12.66 | 13.48 | 12.53 | 13.10 | 4.968M |
| Aug 17, 2026 | 12.78 | 13.25 | 12.39 | 13.00 | 5.433M |
| Aug 14, 2026 | 12.40 | 13.00 | 12.18 | 12.78 | 4.414M |
| Aug 13, 2026 | 11.70 | 12.58 | 11.40 | 12.36 | 5.672M |
| Aug 12, 2026 | 11.92 | 12.45 | 11.50 | 11.77 | 7.797M |
| Aug 11, 2026 | 11.27 | 11.39 | 10.85 | 11.05 | 4.723M |
| Aug 10, 2026 | 11.95 | 12.00 | 10.91 | 11.04 | 5.244M |
| Aug 07, 2026 | 11.95 | 12.21 | 11.61 | 12.01 | 5.124M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Lite Strategy, Inc. | 1.11 |
| AbbVie, Inc. | 257.12 |
| Marker Therapeutics, Inc. | 1.15 |
| TG Therapeutics, Inc. | 53.89 |
| Rezolute, Inc. | 4.22 |
Price Related Metrics
| Price to Book Value | 16.93 |
| Earnings Yield | -1.84% |
| Market Cap | 2.331B |